📖 Pippali, Magadhi, Vaidehi, Chapala, Krishnasarpi, Ushana, Kana🇮🇳 Pipli, Pipal, Pippali, Lendi PippaliFamily: PiperaceaePart: Fruit (dried immature fruit spikes — the primary part used clinically and in all Ayurvedic preparations). Root (Pippali Mula — used in TrikatuClassical Ayurvedic combination of three pungent spices — dry ginger, black pepper, and long pepper — used to enhance bioavailability. and some classical compounds; higher piperineThe active alkaloid in black pepper and long pepper (Pippali) — inhibits CYP3A4 and P-glycoprotein, increasing the bioavailability of many other compounds. concentration in some preparations). Both parts specified by API (Ayurvedic Pharmacopoeia of India). The dried fruit spike contains 4–7% piperine by weight — substantially higher than black pepper (Piper nigrum), which contains 2–4%.
🔓 Open AccessResearch or content that's made freely available to everyone, without a subscription or paywall. — All clinical data freely available
Daily Dose
250 – 1000
Best Time
Before meals — for DeepanaAn Ayurvedic therapeutic action meaning digestive fire stimulant — herbs that kindle and strengthen digestive capacity. (digestive stimulation): 15–30 minutes before eating to prime digestive enzyme secretion. Simultaneously with co-administered herb or drug — for bioavailabilityHow much of a substance actually gets absorbed into your bloodstream and can have an effect on your body — not everything you swallow ends up being used. enhancement: piperine's CYP3A4One specific CYP450 liver enzyme, and the one involved in breaking down the largest share of prescription medications — substances that affect CYP3A4 have a high potential for drug interactions. inhibitory effect occurs during intestinal absorption; it must be present at the same time as the co-administered compound (not before or after) to produce the enhancement effect. The Shoba et al. (1998) study administered piperine and curcuminThe primary active compound in turmeric — anti-inflammatory via NF-kB inhibition; notoriously low oral bioavailability (less than 1%). together in a single dose — peak enhancement occurred within 45–60 minutes.
About Pippali (Piper longum)
Pippali (Piper longum L.) is a climbing perennial vine of the Piperaceae family, cultivated across tropical India and Southeast Asia for its dried immature fruit spikes. Its primary active compoundThe specific chemical(s) within an herb believed to be responsible for its effects on the body., piperine, is a piperidine alkaloidA class of naturally occurring, often bitter-tasting plant compounds that frequently have strong effects on the body — caffeine and morphine are both examples of alkaloids. that inhibits cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gpShort for P-glycoprotein — a protein that pumps certain drugs and compounds back out of cells, which can affect how much of a substance actually stays in your system and whether it reaches certain tissues, including the brain.) — two of the body's most important drug metabolism and efflux systems. This dual inhibition forms the pharmacological basis for piperine's role as a bioavailability enhancer, documented in a human study to increase curcumin absorption by 2,000% (Shoba et al., 1998, Planta Med). A 2024 physiologically based pharmacokinetic modelling study predicted that 20 mg/day piperine increases the area under the curve (AUCArea Under the Curve — in pharmacokinetics, the total amount of drug exposure in the body over time, measured from a blood concentration graph.) of simvastatin by 59%, cyclosporineAn immunosuppressant drug used after organ transplants — metabolised by CYP3A4, making it vulnerable to many drug and herb interactions. by 35%, and multiple other CYP3A4 substrates significantly. Pippali is a primary ingredient in Trikatu (three pungents) — the most widely used classical Ayurvedic bioavailability-enhancing formula — alongside dry ginger (Shunthi) and black pepper (Maricha). It is prescribed across classical Ayurvedic texts for respiratory, digestive, and metabolic conditions, but it carries a clinically important herb-drug interaction profile that must be disclosed to patients taking pharmaceutical medications.
🌍 Habitat:
Native to the Indo-Malayan region. Primarily cultivated in India (Kerala, Karnataka, Assam, and West Bengal), Sri Lanka, Nepal, Indonesia, Malaysia, and the Philippines. Grows as a climbing perennial vine in humid tropical forests and cultivated gardens at low elevations (up to 600 m). Requires high humidity and well-drained soil. Commercially important in Kerala, where it is grown in home gardens and spice plantations alongside black pepper. Not threatened — widely cultivated. Wild populations are less common than cultivated forms.
📖 Historical & Ayurvedic Background
Pippali occupies a unique pharmacological position in Ayurvedic materia medica — it is one of the few single herbs that is simultaneously classified as a primary therapeutic agent AND as a vehicle (anupanaThe vehicle or adjuvant taken alongside an Ayurvedic herb — such as warm milk, honey, or ghee — that modifies or enhances its action. — adjuvant) that enhances the activity of other herbs. This dual role reflects the classical understanding of its Yogavahi property — the ability to carry and amplify the therapeutic effects of substances co-administered with it.
CLASSICAL CLASSIFICATION:
• Charaka Samhita, Sutrasthana 4.14 — Pippali listed in the Brimhaniya Mahakashaya (ten herbs for nourishment and building) — a RasayanaA category of Ayurvedic herbs and practices aimed at rejuvenation, longevity, and strengthening the body's overall resilience — roughly comparable to the modern idea of a tonic or adaptogen. (rejuvenative) classification that initially appears contradictory for a pungent herb, but is explained by Pippali's Ushna viryaIn Ayurveda, the heating or cooling potency of a substance once it's in the body — classified mainly as either heating (ushna) or cooling (shita). (heating potencyThe amount of a substance needed to produce a given effect — a more potent substance needs a smaller dose.) stimulating AgniIn Ayurveda, the body's digestive fire — the capacity to break down food (and experiences) efficiently. Strong agni is considered central to good health; weak agni is linked to toxin buildup. (digestive fire) and improving tissue nourishment through better absorption
• Charaka Samhita, Sutrasthana 25.48 — Pippali described as first in the Phalvarga (fruit group) for its therapeutic breadth; classified as Katu rasaIn Ayurveda, the immediate taste of a substance when it touches the tongue (like sweet, bitter, or astringent) — each taste is believed to have specific effects on the body beyond just flavor. (pungent taste), Laghu (light), Snigdha (unctuous), Ushna virya (heating potency), Madhura vipakaIn Ayurveda, the effect a substance has after it's fully digested — which can be different from how it tastes going in. Thought to influence long-term effects on the body. (sweet post-digestive effect)
• Ashtanga Hridayam (Vagbhata), Sutrasthana 6.168 — prescribes Pippali specifically for Kasa (cough), Shvasa (dyspnoea/asthma), Hikka (hiccough), Arsha (haemorrhoids), Shula (colic), and Gulma (abdominal tumours); the respiratory indications are the most consistently documented across classical texts
• Bhavaprakasha NighantuA classical Ayurvedic materia medica text that categorises medicinal plants, minerals, and foods with their properties., Pippalyadi VargaA classification group in Ayurvedic materia medica — herbs are grouped into Vargas based on their primary therapeutic actions. (16th century CE) — Pippali is the eponymous first herb of its own Varga (classification group); described as KrimighnaAn Ayurvedic therapeutic action meaning antimicrobial or antiparasitic — traditionally used against infections and parasites. (antimicrobialA substance that kills or inhibits the growth of microorganisms including bacteria, viruses, and fungi.), Deepana (digestive stimulant), AnulomanaAn Ayurvedic therapeutic action meaning bowel regulatory — promotes normal downward movement of digestive waste without being a harsh laxative. (bowel regulatory), and Yogavahi (bioavailability enhancer) — the classical correlate of the modern piperine pharmacology
CLASSICAL RESTRICTION — ABHESHAJA STATUS:
A uniquely important classical caution: Charaka Samhita describes Pippali under the concept of Abheshaja — herbs that become non-medicinal or counterproductive when used continuously for long periods. Specifically, continuous use of Pippali is said to eventually aggravate KaphaThe Ayurvedic dosha associated with earth and water — linked to structure, lubrication, and stability in the body. When out of balance, it's associated with sluggishness, weight gain, and congestion. (the doshaOne of three fundamental energies in Ayurveda — Vata, Pitta, and Kapha — believed to govern different physical and mental functions. Ayurvedic practitioners try to keep them in balance for good health. it initially pacifies) and reduce its own efficacyThe maximum effect a substance can produce, regardless of dose — a substance can be very potent but have limited efficacy.. This classical observation is supported by modern pharmacological reasoning: CYP3A4 inhibition by piperine may reduce its own metabolism over time (pharmacokinetic tolerance), and long-term P-gp inhibition could affect gut barrier function.
CLASSICAL VARDHAMANA PIPPALI RASAYANA:
The most well-known classical protocol for Pippali — Vardhamana Pippali Rasayana (increasing dose schedule) — specifies starting at 5 fruits/day and gradually increasing to 50–100 fruits/day over 30 days, then tapering back down. This incremental dose escalation is the classical method to use Pippali's bioavailability-enhancing properties as a Rasayana while avoiding the Abheshaja (counterproductive) effect of constant high-dose use.
TRIKATU — THE CLASSICAL COMBINATION:
Pippali is prescribed most commonly as part of Trikatu (three pungents) — equal proportions of Pippali (long pepper), Maricha (black pepper, Piper nigrum), and Shunthi (dry ginger, Zingiber officinale). Trikatu is the most widely used Ayurvedic digestive and bioavailability-enhancing formula, prescribed as an anupana (vehicle) with almost every other Ayurvedic compound. The classical rationale: each component contributes a different aspect of Deepana (digestive stimulation), while piperine from both Pippali and Maricha provides the bioavailability enhancement documented in modern pharmacology.
Rasa (Taste)
Katu (pungent — primary and dominant taste)
GunaIn Ayurveda, the inherent physical qualities of a substance — such as heavy or light, oily or dry, hot or cold — used to predict how it will affect the body. (Quality)
Laghu (light), Snigdha (unctuous/oily — paradoxically unctuous despite pungent taste, explaining its non-irritating quality compared to black pepper)
Virya (Potency)
Ushna (hot potency — the dominant virya; explains its Deepana, Kaphahara, and Vatahara actions)
Vipaka (Post-digest)
Madhura (sweet post-digestive effect — this is the key distinction from black pepper which has Katu vipaka; Madhura vipaka explains why Pippali is considered nourishing rather than depleting despite its pungent taste)
Dosha Effect
VataThe Ayurvedic dosha associated with movement, air, and space — linked to things like circulation, nerve function, and the mind. When out of balance, it's associated with anxiety, dry skin, and irregular digestion.-Kapha shamaka (pacifies Vata and Kapha doshas — primary actions):• Vata pacification: Snigdha (unctuous) guna and Ushna (hot) virya reduce Vata-associated dryness, cold, and irregular movement• Kapha pacification: Katu (pungent) rasa and Ushna virya dry excess Kapha accumulation in the respiratory and digestive tracts• PittaThe Ayurvedic dosha associated with fire and transformation — linked to digestion, metabolism, and body temperature. When out of balance, it's associated with inflammation, irritability, and acidity.: Madhura vipaka (sweet post-digestive effect) prevents Pitta aggravation at normal doses despite the hot potency; at high doses or with long-term use, may mildly increase Pitta
KarmaIn this context, the specific therapeutic action a substance has on the body — not to be confused with the broader philosophical idea of karma. For example, an herb's karma might be described as a digestive stimulant or nerve tonic. (Action)
Deepana (digestive fire stimulant — primary and most clinically important action), PachanaAn Ayurvedic therapeutic action meaning digestive enzyme promoter — aids breakdown of undigested material (ama). (digestive enzyme promoter), Anulomana (bowel regulatory), Kaphahara (reduces Kapha accumulation), Vatahara (pacifies Vata), Shvasahara (relieves dyspnoea and respiratory distress), Kasahara (relieves cough), Shothahara (anti-inflammatory), Krimighna (antimicrobial), Medohara (reduces excess fat/lipid), Rasayana (rejuvenative — in Vardhamana protocol), Yogavahi (bioavailability enhancer — enhances action of co-administered substances), Brimhaniya (tissue nourishing — at appropriate dose and duration)
✅ Health Benefits
⭐⭐⭐ StrongBioavailability enhancement — CYP3A4 and P-gp inhibition: confirmed in human tissue models (Bhardwaj et al., 2002) and human pharmacokinetic study (Shoba et al., 1998). Piperine at 20 mg increases curcumin AUC by 2,000%. PBPK modelling (2024) predicts clinically significant AUC increases for six CYP3A4 substrate drugs at 20 mg/day piperine. This is the strongest and most clinically important evidence for any action of Pippali.
⭐ PreliminaryRespiratory symptom relief: 1 small study meeting inclusion criteria in a 2025 PRISMA systematic reviewA structured, thorough summary of all the available research on a specific question, following a defined method to reduce bias in what studies get included. (PROSPERO: CRD42024564247) showed symptom improvement. No placeboAn inactive substance given to some participants in a study so researchers can compare it against the real treatment and see whether the treatment's effect is genuinely due to the substance itself.-controlled RCTShort for randomized controlled trial — a type of study where participants are randomly assigned to receive either the treatment being tested or a comparison (often a placebo), which is generally considered a strong form of scientific evidence. of adequate quality has been published. The systematic review explicitly concludes good-quality evidence is absent.
⭐ PreliminaryAnti-inflammatory, thermogenic, antidepressant, anti-obesity: mechanistically documented in animal models and cell studies. No adequately powered standalone human RCT has confirmed any of these endpoints for Piper longum or piperine in humans.
PippaliPiper longumlong pepperbioavailability enhancerTrikatudigestionbloatingcoughrespiratoryDeepanaYogavahipiperinecurcumin absorptiondrug interactionCYP3A4nutrient absorptiondigestive health
🔬 Phytochemistry
ACTIVE COMPOUNDS
Alkaloids: piperine (4–7% of dry fruit weight — primary bioactive; CYP3A4 and P-gp inhibitor)piperlonguminepiperettinepipernonalinepiplartine (piperlongumine — documented anti-cancer activity in vitroLatin for "in glass" — research done in a lab setting (like a test tube or petri dish) rather than in a living organism. Useful for early research, but results don't always hold up the same way in the body.); Essential oils (1–2%): caryophyllenepentadecanebisabolenethujene; Fixed oils (about 6%): palmitic acidlinoleic acid; Other: terpinen-4-olsesaminpiperlongumininesylvatinelongamide
📊 StandardizationA manufacturing process that guarantees an herbal extract contains a consistent, measured amount of its key active compound in every batch — without it, potency can vary a lot between products.: Standardised primarily by piperine content:• API (Ayurvedic Pharmacopoeia of India) Part I Volume V: Pippali fruit must contain not less than 1% piperine by HPLC and not less than 5% alcohol-soluble extractives• Commercial standardised extracts: 95–98% piperine (pharmaceutical-gradeGrading of Recommendations Assessment, Development and Evaluation — a system used to rate the quality and certainty of clinical evidence.; used in BioPerine — the most studied commercial piperine extractA concentrated preparation made by pulling the active compounds out of a raw herb, usually using water, alcohol, or another solvent — generally stronger, dose-for-dose, than the raw plant material., manufactured by Sabinsa Corporation; extensively licensed across supplement brands globally)• BioPerine (Sabinsa Corporation): standardised to minimum 95% piperine by HPLC; used in the majority of published human bioavailability enhancement studies• Standard supplemental dose of piperine for bioavailability enhancement: 5–20 mg alongside the co-administered compound• Note: crude Pippali fruit powder at 500–1,000 mg delivers approximately 20–70 mg piperine — comparable to the doses used in bioavailability enhancement studies, but with variable content depending on source and storage
🧬 Mechanism of Action
📍 Pathways:
Piperine → CYP3A4 inhibition (intestinal and hepatic) → reduced first-pass metabolismThe process where a substance you swallow gets partly broken down by the liver before it ever reaches the rest of your bloodstream — this is a big reason why the same substance can work differently depending on how it's taken. of CYP3A4 substrates → increased oral bioavailability; Piperine → P-glycoprotein (P-gp/ABCB1) efflux pump inhibition → reduced drug ejection from intestinal epithelial cells → increased drug absorption; Piperine → UDP-glucuronosyltransferase (UGT) inhibition → reduced phase II conjugation of substrates → increased systemic exposure; Piperine → intestinal epithelial membrane fluidity enhancement → increased passive diffusion of lipophilic compounds; Piperine → TRPV1 (transient receptor potential vanilloid 1) receptor activation → thermogenic effect and increased gastrointestinal motility; Piperine → NF-kBNuclear factor kappa-B — a protein complex that switches on inflammation-related genes inside cells. A key target in anti-inflammatory research. inhibition → reduced pro-inflammatory cytokine production (anti-inflammatory; animal models); Piperine → AMPKAMP-activated protein kinase — a cellular energy sensor that, when activated, improves glucose uptake and fat burning. Activated by exercise and metformin. activation → lipid oxidation enhancement (anti-obesity; animal models); Piperine → 5-HT1A receptor modulation + BDNFBrain-Derived Neurotrophic Factor — a protein that supports the growth and survival of brain cells. Low levels are linked to depression. upregulation → antidepressant-like effect (animal models)
Pippali's most pharmacologically important mechanism is its dual inhibition of CYP3A4 (cytochrome P450 3A4 — a liver and gut enzyme) and P-glycoprotein (P-gp — an efflux pump in intestinal cells). Together these two systems form the primary first-pass barrier to oral drug absorption. CYP3A4 metabolises approximately 50% of all prescription drugs; P-gp physically ejects absorbed compounds back into the gut lumen. Piperine inhibits both simultaneously, allowing co-administered compounds to bypass these barriers and reach the bloodstream in much higher concentrations.
Sources: Bhardwaj RK et al. (2002) J Pharmacol Exp Ther. 302(2):645-650. DOI: 10.1124/jpet.102.033654; Int J Mol Sci. 2024;25(20):10955. DOI: 10.3390/ijms252010955
Documented human bioavailability enhancement:
Curcumin: +2,000% AUC with 20 mg piperine co-administered with 2 g curcumin in healthy volunteers (Shoba et al., 1998, Planta Med). Note: the 2,000% figure is based on AUC calculations where curcumin-only serum levels were near or below the limit of detection — the relative increase is real but the absolute magnitude reflects the extreme baseline of near-zero curcumin absorption without piperine
Fexofenadine (antihistamine): AUC increased by 68% in 12 healthy volunteers after 10 days of piperine 20 mg/day — via P-gp inhibition (published clinical study, Pharmacy Times 2024 review)
⚖️ Piperine as Bioenhancer vs Pharmaceutical Drug Interaction Risk
Therapeutic Use (intended)
↑ Curcumin absorption +2,000%
↑ Nutrient bioavailability
↑ Co-herb effectiveness
Classical Yogavahi property
Trikatu formula basis
Interaction Risk (unintended)
↑ Cyclosporine levels +35%
↑ Simvastatin levels +59%
↑ Anticonvulsant levels
↑ Immunosuppressant toxicity
Any CYP3A4 substrate affected
The same mechanism that makes piperine therapeutically valuable creates clinically important drug interaction risks. Source: PBPK modelling — Int J Mol Sci. 2024;25(20):10955.
What is NOT established: The anti-obesity, antidepressant, and nootropicA substance believed to support memory, focus, or overall brain function. effects of piperine are demonstrated in animal models but have not been confirmed in adequately powered human RCTs. The thermogenic effect via TRPV1 activation is mechanistically plausible but clinically unquantified. The 2,000% curcumin bioavailability figure has not been independently replicated in a head-to-head human crossover trial comparing curcumin with and without piperine at the same dose — the Shoba (1998) study used industry-sponsored conditions and calculated the increase from near-zero baseline curcumin absorption.
💉 PharmacokineticsThe study of how a substance moves through your body over time — how it's absorbed, distributed, broken down, and eventually removed. & Deep Pharmacology
Piperine is moderately lipophilic (LogP approximately 1.98) with good oral bioavailability in animal models. No formal Phase I human pharmacokinetic study with validated plasma concentration-time curves specifically for piperine from Piper longum has been published as of 2024.
💊 Piperine Pharmacokinetics — Available Data
Oral absorption
Good
LogP 1.98 — moderate lipophilicity
TmaxTime to maximum concentration — how long after taking a dose the substance reaches its peak level in the blood. (time to peak)
Known (animal)
~0.75–1.0 h in rats
CYP3A4 inhibition onset
Rapid
Within 45–60 min post-dose
Human PK formal study
Absent
Not published
Duration of CYP inhibition
Uncertain
Hours to days — not characterised
Human PK data largely absent for piperine from P. longum. Data inferred from BioPerine studies and PBPK modelling. Source: Int J Mol Sci. 2024;25(20):10955.
Key clinical timing consideration: In the Shoba et al. (1998) curcumin study, peak curcumin concentrations with piperine co-administration occurred at 0.25–1.0 hour post-dose. This suggests CYP3A4 inhibition by piperine is rapid in onset — consistent with inhibition occurring in the intestinal wall during absorption rather than requiring prior systemic distribution. For drug interactions, this means piperine consumed in food (black pepper in a meal) could affect drugs taken at the same meal.
BiomarkerA measurable substance or characteristic in the body (like a blood marker) used to track whether something — a disease, treatment, or herb — is having an effect. Effects
BIOMARKER EFFECTS - DOCUMENTED IN HUMAN STUDIESSources: Shoba G et al. (1998) Planta Med; Bhardwaj RK et al. (2002) J Pharmacol Exp Ther; Int J Mol Sci (2024)BIOAVAILABILITY BIOMARKERS (CONFIRMED IN HUMANS): Compound
Effect of Piperine
Magnitude
Study Type---------
-------------------
-----------
----------Curcumin AUC
Increased
+2,000% at 20 mg piperine co-dose
Human PK study (n=8, single dose)Fexofenadine AUC
Increased
+68% after 20 mg/day x 10 days
Human PK study (n=12)Beta-carotene serum levels
Increased
~2-fold increase
Human supplement studyCoenzyme Q10 serum levels
Increased
+31% vs control
Human supplement studyCYP3A4 SUBSTRATE LEVELS (PREDICTED — PBPK MODELLING 2024):Drug
Predicted AUC Increase
Clinical Significance-----
------------------------
---------------------Simvastatin
+59%
HIGH — myopathy risk at standard statin dosesCyclosporine
+35%
HIGH — narrow therapeutic windowTriazolam
+36%
HIGH — sedation riskAlfentanil
+39%
HIGH — narrow therapeutic windowThe dose range where a substance is effective but not yet at a level likely to cause harmful side effects — too little and it may not work, too much and it may become risky. opioidNifedipine
----------ALTAlanine aminotransferase — a liver enzyme in the blood. Elevated levels indicate liver damage, inflammation, or stress.
No significant change at standard doses
Clinical studies up to 4 weeksAST
No significant change at standard doses
Clinical studies up to 4 weeksGastric acid secretion
Decreased
Animal models — not confirmed in humansNOTE ON MISSING DATA: No human RCT measuring primary metabolic, anti-inflammatory, orantidiabetic endpoints for Piper longum as a standalone agent hasbeen completed and published as of 2024 per systematic review(PROSPERO ID: CRD42024564247, Sciencedirect 2025).
📊 Clinical EvidenceData collected from studies involving actual human participants, as opposed to lab or animal studies — generally considered more directly relevant to how something affects people.
Study
Year
n
Dose
Duration
Outcome
Quality
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. (1998)
8 healthy volunteers (human arm); rat groups separately
Single dose; blood sampling over 4 hours
Piperine co-administration increased curcumin AUC by 2,000% vs curcumin alone (p<0.01 at 0.25 and 0.5 h; p<0.001 at 1 h). Serum curcumin undetectable in curcumin-alone arm. No adverse effects reported. Limitation: industry-sponsored (Sabinsa); very small n=8; single dose; curcumin-alone arm near zero absorption makes % calculation extremely sensitive to small numerator changes.
In vitro — cell lines; not an in-patient clinical study
In vitro
Piperine inhibited human P-glycoprotein in Caco-2 bidirectional transport assay. Piperine inhibited human CYP3A4 activity in liver microsomal assay. IC50The concentration of a substance that inhibits 50% of an enzyme in a lab test — lower means more potent. values established at physiologically relevant concentrations. This is the foundational mechanistic study confirming P-gp + CYP3A4 dual inhibition by piperine in human tissue models.
★ In Vitro
Suresh D, Srinivasan K. (2010)
Not confirmed from available data
Single dose
Confirmed absorption of piperine after oral administration in humans. Established that piperine from both Piper nigrum and Piper longum is bioavailable in humans. Limitation: pharmacokinetic endpoints only, not therapeutic outcomes.
★★ Cohort
Physiologically Based Pharmacokinetic (PBPK) Modelling Study. (2024)
Computational model — not a clinical trial
7-day piperine intake modelled
Predicted AUC ratios exceeding 1.25 (the threshold for a clinically significant interaction) for: simvastatin +59%, alfentanil +39%, triazolam +36%, cyclosporine +35%, nifedipine +34%, ritonavir +31%. Authors conclude caution should be exercised when consuming piperine during treatment with CYP3A4 substrate drugs. Limitation: modelling study — clinical confirmation in human drug interaction trials required.
★ In Vitro
2025 Systematic Review — Safety and Efficacy for Acute Respiratory Infections
2 studies met inclusion criteria (1 RCT, 1 NRCT)
Per included studies
One study reported Piper longum improved ARI symptoms including cough frequency, sleep disturbances, sputum production, crepitations, and wheezing. No good-quality RCTs measuring effectiveness vs placebo were found. Conclusion: Piper longum may be beneficial for ARIs but findings require cautious interpretation due to poor methodological quality of available studies.
★★ Cohort
💊 Recommended Dosage
Therapeutic Range
250 – 1000
Traditional Dose
As standalone herb:• Pippali ChurnaA finely powdered Ayurvedic herbal preparation. (fruit powder): 1–3 g/day with honey or ghee — per Charaka Samhita and Bhavaprakasha Nighantu• Pippali Mula Churna (root powder): 1–2 g/dayAs Trikatu (equal parts Pippali + Maricha + Shunthi):• 250–500 mg Trikatu powder with warm water before meals — standard Ayurvedic digestive adjuvantVardhamana Pippali Rasayana (classical graduated dose protocol):• Start with 5 dried Pippali fruits/day; increase by 5 fruits daily up to 50–100 fruits; then taper back down• Course duration: 60–90 days• Vehicle: warm milk with honey• Classical source: Charaka Samhita Chikitsa SthanaA major section or chapter division in classical Ayurvedic texts — for example Sutrasthana (general principles) or Chikitsa Sthana (treatment). 1.2.10-12For piperine-specific bioavailability enhancement:• 5–20 mg piperine (from standardised BioPerine or equivalent) co-administered simultaneously with the compound whose absorption is to be enhanced• Note: dietary black pepper provides approximately 5–15 mg piperine per teaspoon — within the range for bioavailability effects
Best Time
Before meals — for Deepana (digestive stimulation): 15–30 minutes before eating to prime digestive enzyme secretion. Simultaneously with co-administered herb or drug — for bioavailability enhancement: piperine's CYP3A4 inhibitory effect occurs during intestinal absorption; it must be present at the same time as the co-administered compound (not before or after) to produce the enhancement effect. The Shoba et al. (1998) study administered piperine and curcumin together in a single dose — peak enhancement occurred within 45–60 minutes.
Available Forms
Pippali Churna (whole dried fruit powder — Himalaya Drug Company, Dabur, Patanjali Ayurved, Baidyanath; most traditional form); Pippali Mula Churna (root powder — available from Ayurvedic pharmacies); Trikatu Churna (combination of Pippali + Maricha + Shunthi — the most widely available commercial form globally; Himalaya Drug Company, Organic India, Banyan Botanicals); BioPerine (standardised piperine extract, 95–98% piperine — Sabinsa Corporation; licensed to hundreds of supplement brands globally; the form used in published bioavailability studies); Piperine capsules (5 mg, 10 mg, 20 mg standalone piperine — various manufacturers); Curcumin + piperine combination products (ubiquitous in global supplement market; Theracurmin, various brands add BioPerine to turmeric extracts)
💡
Take piperine simultaneously with the compound you want to enhance — co-administration is required; taking piperine an hour before or after does not produce the same enhancement effect2. Standard bioavailability-enhancing dose is 5–20 mg piperine from standardised BioPerine or whole Pippali fruit powder — do not exceed 20 mg/day without considering drug interactions3. If taking pharmaceutical medications, inform your doctor before using any piperine or Pippali supplement — see drug interactions section for specific risks4. Trikatu at standard doses (250–500 mg) delivers approximately 10–25 mg piperine — within the interaction-relevant range5. Dietary black pepper at culinary doses (a few pinches per meal) delivers approximately 5–15 mg piperine — below the threshold for major drug interactions but potentially relevant with very narrow therapeutic window drugs like cyclosporine or tacrolimusA potent immunosuppressant used in transplant patients — extremely narrow therapeutic window; small changes in drug levels can cause rejection or toxicity.
💫 SynergyWhen two or more substances combined produce a stronger or different effect than you'd expect from simply adding up their individual effects. — Works Well With
🌿 Maricha (Piper nigrum L. — black pepper) — co-primary ingredient in Trikatu; also contains piperine (2–4%); classical pungent pair with Pippali | Shunthi (Zingiber officinale Roscoe — dry ginger) — third Trikatu ingredient; gingerols and shogaols add thermogenic and anti-nausea activity; modulates gastrointestinal motility independently of piperine | Haridra (Curcuma longa L. — turmeric) — the most important co-herb combination; curcumin bioavailability increases 2🌿 000% with piperine co-administration; the most researched herb-piperine combination globally | Ashwagandha (Withania somnifera (L.) Dunal) — classical Rasayana pairing; withanolidesSteroidal lactone compounds unique to Ashwagandha — responsible for its cortisol-reducing and testosterone-supporting effects. have moderate oral bioavailability that may be further enhanced by piperine co-administration | Guggul (Commiphora wightii (Arnott) Bhandari) — classical combination in many Ayurvedic lipid-lowering formulas; piperine enhances guggulsteroneThe active steroidal compound in Guggul (Commiphora wightii) — inhibits FXR receptor and modulates bile acid metabolism. absorption
⚠️ Safety Profile
Side Effects
REPORTED AT STANDARD DOSES (250–1,000 mg/day, up to 4 weeks):• Mild gastrointestinal warmth or burning sensation — consistent with TRPV1 activation; generally mild and transient• Increased gastric acid secretion at high doses — may aggravate peptic ulcer disease or GERD (gastro-oesophageal reflux disease)• Mild diaphoresis (sweating) — from thermogenic activity via TRPV1AT HIGH DOSES OR PROLONGED USE: • Pitta aggravation (Ayurvedic concept) — irritability, skin rash, loose stools; documented in classical texts• Classical Abheshaja effect — reduced therapeutic benefit with continuous long-term use• Spermatogenesis impairment — documented in animal studies at high doses (100 mg/kg in rats); not confirmed in human studies but warrants caution in men trying to conceive at high dosesSAFETY NOTE — DRUG INTERACTIONS ARE THE PRIMARY SAFETY CONCERN: The most clinically important adverse effect of Pippali is not a direct side effect of the herb itself — it is the unintended increase in blood levels of co-administered pharmaceutical medications through CYP3A4 and P-gp inhibition. At standard supplement doses (20 mg piperine/day), simvastatin AUC is predicted to increase by 59% — raising myopathy risk. Cyclosporine AUC predicted +35% — potentially causing immunosuppressant toxicity in transplant recipients. These are not theoretical risks — they follow from confirmed human-tissue mechanistic data and PBPK modelling validated against clinical observations.
Contraindications
Peptic ulcer disease or active gastritis — Ushna (hot) virya increases gastric acid secretion; avoid or use with food and monitoring• GERD (gastro-oesophageal reflux disease) — thermogenic and acid-stimulating effect may worsen symptoms• Pregnancy — uterine stimulant effects documented in animal models at high doses; avoid during pregnancy particularly in first trimester• Concurrent use of narrow therapeutic window drugs (cyclosporine, tacrolimus, warfarinA blood-thinning medication (anticoagulant) — requires careful monitoring because many drugs and herbs affect its levels in the blood., digoxin, antiepileptics) — CYP3A4 and P-gp inhibition raises blood levels of these drugs unpredictably; see interactions section• Concurrent statinsA class of cholesterol-lowering drugs (atorvastatin, simvastatin, rosuvastatin) — inhibit HMG-CoA reductase to reduce LDL production. at high doses — simvastatin AUC increase of 59% predicted; myopathy risk significantly elevated• Active hepatitis or severe liver disease — impaired hepatic metabolism may amplify piperine's already-inhibitory effect on drug clearance• Male infertility workup — animal data suggest high-dose piperine may impair spermatogenesis; avoid at doses above dietary range
Max Safe Dose
20 mg/day piperine (standardised extract) for up to 4 weeks — based on doses used in published human studies without reported adverse events. Beyond 4 weeks: no controlled human safety data. Classical Vardhamana Pippali Rasayana uses higher fruit counts (up to 50–100 fruits/day) for limited courses — not equivalent to standardised extract doses. Do not use piperine supplements without disclosing to your treating physician if you take any prescription medication.
❓ Frequently Asked Questions
What are the side effects of Pippali (Piper longum)?
REPORTED AT STANDARD DOSES (250–1,000 mg/day, up to 4 weeks):• Mild gastrointestinal warmth or burning sensation — consistent with TRPV1 activation; generally mild and transient• Increased gastric acid secretion at high doses — may aggravate peptic ulcer disease or GERD (gastro-oesophageal reflux disease)• Mild diaphoresis (sweating) — from thermogenic activity via TRPV1AT HIGH DOSES OR PROLONGED USE:• Pitta aggravation (Ayurvedic concept) — irritability, skin rash, loose stools; documented in classical texts• Classical Abheshaja effect — reduced therapeutic benefit with continuous long-term use• Spermatogenesis impairment — documented in animal studies at high doses (100 mg/kg in rats); not confirmed in human studies but warrants caution in men trying to conceive at high dosesSAFETY NOTE — DRUG INTERACTIONS ARE THE PRIMARY SAFETY CONCERN:The most clinically important adverse effect of Pippali is not a direct side effect of the herb itself — it is the unintended increase in blood levels of co-administered pharmaceutical medications through CYP3A4 and P-gp inhibition. At standard supplement doses (20 mg piperine/day), simvastatin AUC is predicted to increase by 59% — raising myopathy risk. Cyclosporine AUC predicted +35% — potentially causing immunosuppressant toxicity in transplant recipients. These are not theoretical risks — they follow from confirmed human-tissue mechanistic data and PBPK modelling validated against clinical observations.
What is the recommended dosage of Pippali (Piper longum)?
250 – 1000. Traditionally: As standalone herb:• Pippali Churna (fruit powder): 1–3 g/day with honey or ghee — per Charaka Samhita and Bhavaprakasha Nighantu• Pippali Mula Churna (root powder): 1–2 g/dayAs Trikatu (equal parts Pippali + Maricha + Shunthi):• 250–500 mg Trikatu powder with warm water before meals — standard Ayurvedic digestive adjuvantVardhamana Pippali Rasayana (classical graduated dose protocol):• Start with 5 dried Pippali fruits/day; increase by 5 fruits daily up to 50–100 fruits; then taper back down• Course duration: 60–90 days• Vehicle: warm milk with honey• Classical source: Charaka Samhita Chikitsa Sthana 1.2.10-12For piperine-specific bioavailability enhancement:• 5–20 mg piperine (from standardised BioPerine or equivalent) co-administered simultaneously with the compound whose absorption is to be enhanced• Note: dietary black pepper provides approximately 5–15 mg piperine per teaspoon — within the range for bioavailability effects.
🧪 Expert Note
Pippali is the herb that most clearly demonstrates why Ayurvedic pharmacology cannot be treated as a collection of folk remedies. The Yogavahi concept — a substance that enhances the activity of everything co-administered with it — is one of the most pharmacologically specific and accurate observations in the entire classical literature. It predates the discovery of CYP450Short for cytochrome P450 — a family of liver enzymes responsible for breaking down a huge number of medications and other substances. Many drug interactions happen because two substances compete for the same CYP450 enzyme. enzymes by approximately 2,000 years.
The clinical implication today is both positive and concerning. On the positive side, piperine supplementation genuinely does what the classical texts claimed it does — it makes other herbs and drugs work better. On the concerning side, it makes drugs work better regardless of whether you want them to. A patient taking cyclosporine after a kidney transplant who starts Trikatu because an Ayurvedic practitioner recommended it for digestion is now effectively taking a higher dose of cyclosporine than their nephrologist prescribed — with potential toxicity consequences that neither practitioner will initially attribute to the herb.
The 2024 PBPK modelling study (Int J Mol Sci. DOI: 10.3390/ijms252010955) makes this concrete: 20 mg/day piperine (a standard supplement dose, achievable from Trikatu at typical doses) increases simvastatin AUC by 59%. That is the difference between a 20 mg statin prescription and what is functionally a 32 mg exposure. The prescribing cardiologist does not know this is happening.
Every Ayurvedic practitioner prescribing Trikatu or Pippali should ask their patients what pharmaceutical medications they take. This is not optional due diligence — it is the primary safety issue for this herb.
📜 Trikatu Churna — equal parts Pippali + Maricha + Shunthi; the most widely used Ayurvedic formula globally; prescribed as anupana (vehicle) with virtually every other Ayurvedic compound | Trikatu tablets — commercial form widely available (Himalaya📜 Dabur📜 Patanjali Ayurved📜 Banyan Botanicals) | Chyawanprash — classical multi-herb Rasayana jam; Pippali is one of 40+ ingredients | Dashamularishta — fermented classical preparation; Pippali among primary ingredients | Sitopaladi Churna — classical respiratory formula containing Pippali📜 candy sugar📜 cardamom📜 cinnamon📜 and Vamshalochana | Vardhamana Pippali Rasayana — classical graduated dose protocol using Pippali fruit with milk and honey | Pippali Mula KwathaAn Ayurvedic water decoction — prepared by boiling herbs in water, usually until the volume is reduced to one quarter. — water decoctionA traditional preparation method where tougher plant parts (like roots, bark, or seeds) are simmered in water for an extended time to extract their active compounds. of Pippali root for Vata disorders | Agastya Haritaki — classical respiratory compound containing Pippali as primary pungent ingredient
⚠️ Drug Interaction Checker
Check if this herb interacts with your medication. Type the drug name below.
⚠ This database is for informational purposes only. Always consult your doctor before combining herbs with medications.